Citation Impact
Citing Papers
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks
2013
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Selective Cyclooxygenase-2 Inhibition by Nimesulide in Man
1998
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
ANTIMICROBIAL THERAPY IN THE ELDERLY
2001
The influence of drug-like concepts on decision-making in medicinal chemistry
2007 Standout
Thromboxane-B2levels in serum of rabbits receiving a single intravenous dose of aqueous extract of garlic and onion
2000
Practice Guidelines for the Treatment of Candidiasis
2000
The serotonin syndrome scale: first results on validity
1998
Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children
2006
Side effects of opioids during short-term administration: effect of age, gender, and race
2003
Severe and complicated malaria
1990 Standout
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Effect of garlic on cardiovascular disorders: a review
2002 Standout
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Prospective study of fluconazole therapy in systemic neonatal fungal infection
1997
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Ageing and infection
2002 Standout
The Serotonin Syndrome
2005 Standout
Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses
1997
Selective Alteration of Personality and Social Behavior by Serotonergic Intervention
1998
Penetration of Antibacterials into Bone
2009
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
2001 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Pilot Study of Nasal Morphine-Chitosan for the Relief of Breakthrough Pain in Patients With Cancer
2002
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
2001
Mycoses in Pediatric Patients
2006
Antifungal Agents in Children
2005
Paroxetine: A Review
2001
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
2014 Standout
Herb-Drug Interactions
2005 Standout
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight.
2000 Standout
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
2001
Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine
2005
Fluconazole
1995
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Candida Infections of Medical Devices
2004 Standout
Clinical Pharmacokinetics of Antimalarial Drugs
1985
Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics
2001
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
2010
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
2012
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
2006
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Prophylactic Fluconazole Is Effective in Preventing Fungal Colonization and Fungal Systemic Infections in Preterm Neonates: A Single-Center, 6-Year, Retrospective Cohort Study
2005
Population Pharmacokinetics of Fluconazole in Young Infants
2008
Current and Emerging Azole Antifungal Agents
1999 Standout
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Prospective Analysis of Factors Related to Migraine Attacks: The PAMINA Study
2007 Standout
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Safety and Tolerability of Fluconazole in Children
1999
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
1998
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Clinical Pharmacokinetics of Quinidine
1980
The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans
1997
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Candida Infections of the Genitourinary Tract
2010
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Guidelines for Treatment of Candidiasis
2004 Standout
Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials
2002
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
Azithromycin—Spectrum of Activity, Pharmacokinetics, and Clinical Applications
1992
Part 14: Pediatric Advanced Life Support
2010 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of Peter E. Coates being referenced
Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection
1987
Effects of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine
2001
An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers
1991
Modeling and Simulation for Clinical Trial Design Involving a Categorical Response: A Phase II Case Study with Naratriptan
2001
Influence of liver cirrhosis on sertraline pharmacokinetics
1996
Age and the Pharmacokinetics of Morphine
1989
Pharmacokinetics of fluconazole in pediatric patients
1994
Pharmacokinetics and metabolism of zamifenacin in mouse, rat, dog and man
1996
Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.
1980
Determination of Quinidine and its major metabolites by high-performance liquid chromatography
1979